Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Wai-Hong Chen"'
Autor:
WAI-HONG CHEN, CHU-PAK LAU
Publikováno v:
Journal of the Hong Kong College of Cardiology. 7:109-118
Publikováno v:
Journal of the Hong Kong College of Cardiology. 8:162-164
Publikováno v:
Journal of the Hong Kong College of Cardiology. 14
Autor:
Wai-Hong Chen, Chu-Pak Lau, Pui-Yin Lee, Hung-Fat Tse, Xi Cheng, William Ng, Jeanette Yat-Yin Kwok
Publikováno v:
The American Journal of Medicine. 120:631-635
We sought to determine the clinical significance of aspirin resistance measured by a point-of-care assay in stable patients with coronary artery disease (CAD).We used the VerifyNow Aspirin (Accumetrics Inc, San Diego, Calif) to determine aspirin resp
Publikováno v:
The American Journal of Cardiology. 98:S11-S17
Numerous clinical trials have demonstrated that aspirin is effective in secondary prevention and in high-risk primary prevention of adverse cardiovascular events. However, a constellation of clinical and laboratory evidence exists that demonstrates d
Autor:
Wai-Hong Chen
Publikováno v:
Current Cardiology Reports. 8:301-306
Platelets play a pivotal role in the pathophysiology of ischemic complications of atherosclerotic cardiovascular disease. Aspirin and clopidogrel are oral antiplatelet drugs that have been shown to reduce adverse clinical events across the wide spect
Autor:
Allen T. Chwang, Chu-Pak Lau, Raymond H. Chan, Stephen W.L. Lee, Pui-Yin Lee, Hung-Fat Tse, Elizabeth O. Y. Lau, Wai-Hong Chen
Publikováno v:
Journal of Hypertension. 24:723-730
OBJECTIVE Current arterial transfer functions have low capability in predicting aortic augmentation index (AIx) from radial pulse contour (RPC), because of the difficulty in accurately identifying the merging point (inflection point) in the derived a
Autor:
Stephen W.L. Lee, Wai-Hong Chen, Hung-Fat Tse, Xi Cheng, Chu-Pak Lau, Pui-Yin Lee, Jeanette Yat-Yin Kwok, William Ng
Publikováno v:
The American Journal of Cardiology. 96:760-763
Previous studies have shown that more complete platelet inhibition improves the coronary flow reserve (CFR), a measure of microvascular integrity, in patients undergoing percutaneous coronary intervention (PCI). We hypothesized that patients with asp
Publikováno v:
Catheterization and Cardiovascular Interventions. 61:360-363
The FilterWire EX is one of the filter protection devices developed as alternatives to balloon occlusion system for percutaneous coronary intervention. Its use has been recommended in vessels between 3.5 and 5.5 mm in diameter and no data are availab
Publikováno v:
The American Journal of Cardiology. 88:774-777